P1195: A PROSPECTIVE STUDY OF TARGETED SEQUENTIAL IMMUNOTHERAPY. IN PATIENTS WITH RELAPSED REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA.

• Yuelu Guo,
• Kai Hu,
• Xiaoyan Ke,
• Teng Xu,
• Shaomei Feng,
• Peihao Zheng,
• Lixia MA,
• Fan Yang,
• Hui Shi,
• Biping Deng,
• Liu Rui,
• Zhonghua Fu

Affiliations

Yuelu Guo

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Kai Hu

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Xiaoyan Ke

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Teng Xu

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Shaomei Feng

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Peihao Zheng

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Lixia MA

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Fan Yang

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Hui Shi

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Biping Deng

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Liu Rui

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing

Zhonghua Fu

1 GoBroad Boren Hospital, Department of Lymphoma and Myeloma Research Center, Beijing